IL1B and infection: Results from our experiments with treatment of BMDMs with CA and ∆yopK Yptb mutant infection showed that there was a nonsignificant decrease in IL-1β release which can be attributed to the inhibition of NLRP3 but not of the NLRC4 inflammasome.